Skip to content

The effect of ciprofol intravenous anesthesia on the postoperative recovery of patients undergoing laparoscopic abdominal surgery: A randomized controlled trial

The effect of ciprofol total intravenous anesthesia on the postoperative recovery of patients undergoing laparoscopic abdominal surgery: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123244
Enrollment
Unknown
Registered
2026-04-23
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic abdominal surgery

Interventions

Ciprofol group:Anesthesia induction: 0.5mg/kg intravenous injection, with an additional dose of 0.2mg/kg. Anesthesia maintenance: Intravenous infusion at a rate of 0.4~2.4 mg/kg/h until the end of sur
Propofol group:Anesthesia induction: 2.5mg/kg intravenous injection, with an additional dose of 1mg/kg. Anesthesia maintenance: Intravenous infusion at a rate of 4~12 mg/kg/h until the end of surgery.

Sponsors

The Second Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-65 2) ASA classification of I-II 3) Patients who are scheduled to undergo laparoscopic abdominal surgery under general anesthesia

Exclusion criteria

Exclusion criteria: 1) Those who have a known history of allergy to the relevant drugs in this scheme; 2) Individuals with severe neurological diseases (such as epilepsy, Parkinson's disease) or those who have experienced a stroke or undergone intracranial surgery within the past 6 months; 3) Individuals with alcohol or drug addiction (physically and psychologically dependent on alcohol or drugs); 4)Hb50mmHg), unstable angina pectoris, or cardiac function NYHA classification of III or above; 11) Patients with liver dysfunction (Child-Pugh Class B and C); 12) Hypothyroidism/Subclinical hypothyroidism; 13)Myasthenia gravis ; 14) Adrenal insufficiency;

Design outcomes

Primary

MeasureTime frame
Quality of Recovery Score;Consciousness recovery time;

Secondary

MeasureTime frame
Mean arterial pressure;Heart rate;Tracheal tube removal time;Post-Anesthesia Care Unit dwell time;Patients with Postoperative NRS Score > 3 at 24 Hours;PONV at 24 Hours;vasoactive drugs;Injection pain;

Countries

China

Contacts

Public ContactWang Zhao

The Second Affiliated Hospital of Zunyi Medical University

zy2ane@126.com+86 139 8428 2588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026